Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

125.00 

2.42 2.0%

as of Apr 03 '20

52 Week Range:

108.00 155.16


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) 8.60
11.27
12.11
13.89
18.52
20.74
22.20
27.73
30.80
31.69
30.51
growth rate 31.1% 7.5% 14.7% 33.3% 12.0% 7.0% 24.9% 11.1% 2.9% -3.7%
Earnings BIT 1,292.98
1,379.70
1,119.53
1,844.86
1,931.58
2,373.08
2,814.59
2,180.90
2,179.20
2,795.70
3,101.50
growth rate 6.7% -18.9% 64.8% 4.7% 22.9% 18.6% -22.5% -0.1% 28.3% 10.9%
Avg.PE 47.39
28.57
44.05
18.42
16.95
17.21
20.49
21.45
16.87
21.82
22.64
growth rate -39.7% 54.2% -58.2% -8.0% 1.5% 19.1% 4.7% -21.4% 29.3% 3.8%
ROA 9.03
7.54
6.21
8.58
8.33
7.61
7.97
7.25
7.88
5.46
5.42
growth rate -16.5% -17.6% 38.2% -2.9% -8.6% 4.7% -9.0% 8.7% -30.7% -0.7%
ROE 17.42
13.95
10.74
14.15
14.19
13.32
13.02
11.36
14.27
10.94
10.10
growth rate -19.9% -23.0% 31.8% 0.3% -6.1% -2.3% -12.8% 25.6% -23.3% -7.7%
ROIC 13.22
11.16
9.24
12.10
11.77
10.78
11.15
10.15
10.98
7.53
7.27
growth rate -15.6% -17.2% 31.0% -2.7% -8.4% 3.4% -9.0% 8.2% -31.4% -3.5%
Cur. Ratio 1.40
1.53
1.89
1.73
1.50
1.80
2.01
1.75
1.27
0.97
1.43
growth rate 9.3% 23.5% -8.5% -13.3% 20.0% 11.7% -12.9% -27.4% -23.6% 47.4%
Quick Ratio 0.77
0.83
1.32
1.17
0.86
1.18
1.45
1.23
0.77
0.60
0.87
growth rate 7.8% 59.0% -11.4% -26.5% 37.2% 22.9% -15.2% -37.4% -22.1% 45.0%
Leverage 1.92
1.78
1.68
1.62
1.77
1.73
1.55
1.58
2.04
1.97
1.77
growth rate -7.3% -5.6% -3.6% 9.3% -2.3% -10.4% 1.9% 29.1% -3.4% -10.2%
Balance Sheet Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 1,377.94
1,511.21
1,749.46
2,404.54
2,575.94
2,721.24
3,445.80
2,985.10
3,186.10
3,521.80
growth rate 9.7% 15.8% 37.4% 7.1% 5.6% 26.6% -13.4% 6.7% 10.5%
Acct.Payable 5,016.50
4,001.30
4,279.20
4,597.60
growth rate -20.2% 7.0% 7.4%
Cur.Assets 3,045.28
4,115.92
4,517.14
4,945.16
5,982.22
7,185.24
9,431.30
7,836.70
6,665.10
6,850.00
growth rate 35.2% 9.8% 9.5% 21.0% 20.1% 31.3% -16.9% -15.0% 2.8%
Total Assets 12,720.55
15,449.01
17,515.96
23,612.19
25,970.68
27,335.56
36,991.70
48,222.20
45,295.30
46,648.60
growth rate 21.5% 13.4% 34.8% 10.0% 5.3% 35.3% 30.4% -6.1% 3.0%
Cash 285.76
1,357.55
1,287.46
423.37
1,323.49
2,456.02
3,005.60
790.80
963.70
630.30
growth rate 375.1% -5.2% -67.1% 212.6% 85.6% 22.4% -73.7% 21.9% -34.6%
Inventory 830.79
782.88
965.95
1,404.46
1,429.68
1,406.11
1,782.80
1,573.10
1,709.40
1,840.80
growth rate -5.8% 23.4% 45.4% 1.8% -1.7% 26.8% -11.8% 8.7% 7.7%
Cur.Liabilities 1,996.51
2,176.77
2,605.50
3,289.20
3,316.09
3,569.40
5,396.40
6,170.40
6,874.00
4,792.30
growth rate 9.0% 19.7% 26.2% 0.8% 7.6% 51.2% 14.3% 11.4% -30.3%
Liabilities 5,586.83
6,279.76
6,706.21
10,284.44
10,978.08
9,686.99
13,613.60
24,531.90
22,292.50
20,290.40
growth rate 12.4% 6.8% 53.4% 6.7% -11.8% 40.5% 80.2% -9.1% -9.0%
LT Debt 2,650.00
1,856.94
2,277.69
2,194.83
4,105.04
4,168.74
2,709.49
3,401.50
12,025.20
9,674.20
10,327.40
growth rate -29.9% 22.7% -3.6% 87.0% 1.6% -35.0% 25.5% 253.5% -19.6% 6.8%
Equity 9,085.69
7,133.79
9,169.25
10,809.75
13,327.74
14,992.61
17,648.57
23,378.10
23,690.30
23,002.80
26,358.20
growth rate -21.5% 28.5% 17.9% 23.3% 12.5% 17.7% 32.5% 1.3% -2.9% 14.6%
Common Shares 659.00
672.00
671.00
683.00
701.00
713.00
711.00
716.00
8.00
8.10
8.10
growth rate 2.0% -0.2% 1.8% 2.6% 1.7% -0.3% 0.7% -98.9% 1.3% 0.0%
Cash Flow Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 162.07
140.15
143.88
191.11
256.94
361.32
434.80
465.40
512.90
589.60
619.60
growth rate -13.5% 2.7% 32.8% 34.5% 40.6% 20.3% 7.0% 10.2% 15.0% 5.1%
Cash Dividends 34.28
27.86
32.88
52.21
48.33
68.12
41.08
227.70
354.10
399.80
378.30
growth rate -18.7% 18.0% 58.8% -7.4% 41.0% -39.7% 454.3% 55.5% 12.9% -5.4%
Cash From OA 1,645.78
1,352.05
1,419.75
2,084.35
2,070.57
2,692.39
2,826.65
3,758.40
3,801.80
3,521.80
3,477.80
growth rate -17.9% 5.0% 46.8% -0.7% 30.0% 5.0% 33.0% 1.2% -7.4% -1.3%
FCF per Share 1.45
1.84
1.69
1.99
2.30
3.16
2.86
3.47
4.08
4.60
3.18
growth rate 26.9% -8.2% 17.8% 15.6% 37.4% -9.5% 21.3% 17.6% 12.8% -30.9%
Sale Purchase of Stock 132.90
249.00
164.50
4.40
growth rate 87.4% -33.9% -97.3%
FCF 1,484.00
1,665.00
1,612.00
1,867.00
2,292.00
2,956.00
3,034.00
3,161.00
3,169.00
2,932.00
2,858.00
growth rate 12.2% -3.2% 15.8% 22.8% 29.0% 2.6% 4.2% 0.3% -7.5% -2.5%
Income Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 8,600.00
9,234.89
8,818.18
9,894.42
12,685.75
14,396.50
15,072.63
12,866.90
14,433.70
16,882.40
18,329.70
growth rate 7.4% -4.5% 12.2% 28.2% 13.5% 4.7% -14.6% 12.2% 17.0% 8.6%
Op.Income 1,359.69
1,216.11
1,615.90
2,063.40
2,495.36
2,581.93
2,045.00
2,162.20
2,750.90
3,021.20
growth rate -10.6% 32.9% 27.7% 20.9% 3.5% -20.8% 5.7% 27.2% 9.8%
IBT 1,272.27
1,123.39
1,757.82
1,929.85
2,373.71
2,811.43
2,086.20
2,039.40
2,611.30
2,938.80
growth rate -11.7% 56.5% 9.8% 23.0% 18.4% -25.8% -2.2% 28.0% 12.5%
Net Income 958.29
908.00
1,413.60
1,712.64
1,886.01
2,124.74
2,598.40
3,357.40
2,553.70
2,492.10
growth rate -5.3% 55.7% 21.2% 10.1% 12.7% 22.3% 29.2% -23.9% -2.4%
EPS 2.10
1.98
1.73
2.64
3.11
3.36
3.80
3.63
4.74
3.65
3.53
growth rate -5.7% -12.6% 52.6% 17.8% 8.0% 13.1% -4.5% 30.6% -23.0% -3.3%
Gross Profit 5,040.90
4,320.31
4,162.91
5,049.31
6,446.43
7,422.23
7,850.57
6,849.50
7,771.10
9,334.60
10,192.50
growth rate -14.3% -3.6% 21.3% 27.7% 15.1% 5.8% -12.8% 13.5% 20.1% 9.2%
R&D 527.58
498.82
610.22
802.99
897.12
985.42
769.40
861.40
975.10
1,128.80
growth rate -5.5% 22.3% 31.6% 11.7% 9.8% -21.9% 12.0% 13.2% 15.8%

Quarterly Statements

Item Name Mar '17 Jun '17 Sep '17 Dec '17 Mar '18
Earnings BIT 625.50
685.50
769.70
1,020.80
752.20
growth rate 9.6% 12.3% 32.6% -26.3%
Balance Sheet Mar '17 Jun '17 Sep '17 Dec '17 Mar '18
Acct.Receivable 3,034.90
3,214.80
3,254.60
3,521.80
3,270.70
growth rate 5.9% 1.2% 8.2% -7.1%
Acct.Payable 3,782.10
4,033.10
4,205.30
4,597.60
4,344.20
growth rate 6.6% 4.3% 9.3% -5.5%
Cur.Assets 6,318.90
6,256.60
6,260.20
6,850.00
7,075.10
growth rate -1.0% 0.1% 9.4% 3.3%
Total Assets 45,245.10
45,646.80
45,851.30
46,648.60
47,145.20
growth rate 0.9% 0.5% 1.7% 1.1%
Cash 803.90
726.40
648.60
630.30
1,045.70
growth rate -9.6% -10.7% -2.8% 65.9%
Inventory 1,764.90
1,791.70
1,892.30
1,840.80
1,949.10
growth rate 1.5% 5.6% -2.7% 5.9%
Cur.Liabilities 6,003.10
4,202.60
4,387.50
4,792.30
4,442.90
growth rate -30.0% 4.4% 9.2% -7.3%
Liabilities 21,459.30
21,056.80
20,475.90
20,290.40
19,955.30
growth rate -1.9% -2.8% -0.9% -1.7%
LT Debt 9,729.30
11,422.50
10,726.80
10,327.40
10,410.70
growth rate 17.4% -6.1% -3.7% 0.8%
Equity 23,785.80
24,590.00
25,375.40
26,358.20
27,189.90
growth rate 3.4% 3.2% 3.9% 3.2%
Common Shares 8.10
8.10
8.10
8.10
8.10
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '17 Jun '17 Sep '17 Dec '17 Mar '18
Capital Expenditures 158.60
147.90
139.30
173.80
137.90
growth rate -6.8% -5.8% 24.8% -20.7%
Cash Dividends 86.60
97.30
97.10
97.30
97.50
growth rate 12.4% -0.2% 0.2% 0.2%
Cash From OA 560.20
1,010.50
1,072.40
834.70
828.90
growth rate 80.4% 6.1% -22.2% -0.7%
Sale Purchase of Stock -43.90
15.30
13.20
19.80
23.20
growth rate 100.0% -13.7% 50.0% 17.2%
FCF 401.60
862.60
933.10
660.90
691.00
growth rate 114.8% 8.2% -29.2% 4.6%
Income Statement Mar '17 Jun '17 Sep '17 Dec '17 Mar '18
Sales 4,205.70
4,510.10
4,528.20
5,085.70
4,695.40
growth rate 7.2% 0.4% 12.3% -7.7%
Op.Income 623.90
690.60
767.50
946.10
743.00
growth rate 10.7% 11.1% 23.3% -21.5%
IBT 585.20
644.80
729.80
979.00
713.10
growth rate 10.2% 13.2% 34.2% -27.2%
Net Income 506.10
557.30
572.10
856.60
566.60
growth rate 10.1% 2.7% 49.7% -33.9%
EPS
growth rate
Gross Profit 2,334.30
2,482.30
2,536.80
2,839.10
2,643.60
growth rate 6.3% 2.2% 11.9% -6.9%
R&D 267.40
283.30
279.20
298.90
298.70
growth rate 6.0% -1.5% 7.1% -0.1%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (47.19)

YOY Growth Grade:

D (43.83)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 30.83 30.83 20.65
EPS / Growth 4.05

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.3% 11.3% 11.3%
Future PE 20.65 24.71 24.71
Future EPS 11.85 11.85 11.85
Value Price
MOS %
60.47
-51.6%
72.35
-42.1%
72.35
-42.1%
MOS Price 30.24 36.18 36.18
IRT 13.23 13.23 13.23

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.